NYSE:FMS • US3580291066
Overall FMS gets a fundamental rating of 4 out of 10. We evaluated FMS against 101 industry peers in the Health Care Providers & Services industry. FMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. FMS has a bad growth rate and is valued cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 1.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.89 | ||
| Fwd PE | 9.32 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.43 | ||
| EV/EBITDA | 6.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
22.65
-0.01 (-0.04%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.89 | ||
| Fwd PE | 9.32 | ||
| P/S | 0.57 | ||
| P/FCF | 6.43 | ||
| P/OCF | 4.49 | ||
| P/B | 0.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.41 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 1.78 |
ChartMill assigns a fundamental rating of 4 / 10 to FMS.
ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 4 / 10.
The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 16.67% in the next year.
The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.